Summarized by Masters of Longevity from Nature - Biotechnology.
A study describes a bioadaptive nanoparticle therapy that sequentially delivers NAD+ and genipin to coordinate mitochondrial protection and metabolic repair after myocardial infarction.
Key Takeaways
- Researchers developed nanoparticles that first release NAD+ and subsequently release genipin to match post-infarct metabolic phases.
- The sequential delivery strategy aims to protect mitochondria early and restore metabolic function later in injured myocardium.
- In preclinical models the bioadaptive nanomedicine promoted functional recovery of the heart compared with single interventions.
